Revolutionising Pharma: The Rise of Diamond-Shaped Structures and Digital Platform based Operating Models

The pharmaceutical industry is undergoing a profound transformation, driven by the rapid advancements in generative AI, robotic process automation (RPA), the digitalisation of business processes and the emergence of digital products. Traditionally, the industry has relied on hierarchical models characterised by rigid, top-down decision-making processes and siloed departments that often stifle innovation and slow down response times to market changes. These conventional structures are increasingly inadequate in addressing the complexities and demands of today’s fast-paced, tech-driven world. The need for agility, rapid innovation, and cross-functional collaboration has never been more critical, particularly as pharmaceutical companies strive to bring new treatments to market quickly and efficiently while maintaining high safety and efficacy standards. To meet these challenges, there is a trend towards more diamond-shaped organisational structures and digital platform-based operating models, which promise to enhance flexibility, responsiveness, and collaborative efforts across the industry.

Diamond-Shaped Structures: Breaking Down Silos

Traditional pyramid-shaped, hierarchical models in pharma, characterised by rigid top-down decision-making and siloed departments, are being replaced by diamond-shaped structures. This organisational form features increased RPA and flatter hierarchies, promoting cross-functional, agile teamwork and decentralised decision-making. By nurturing collaboration and agile decision-making across diverse teams, the development and distribution of drugs are accelerated.
Diamond-shaped structures emphasise skill diversity and employee empowerment, allowing individuals to contribute and innovate across various functions and levels. This approach aligns with findings from research on team dynamics, which highlight the importance of cooperation and the detrimental effects of pro-self behaviours. Pharmaceutical companies can drive innovation and improve team effectiveness by prioritising prosocial behaviours and nurturing a collaborative environment.

Digital Platform based Operating Models: Integrating Technology Seamlessly

In today’s digital age, pharma organisations are increasingly viewing their products and services through a digital lens. Digital platform-based operating models, such as AstraZeneca Amaze platform, support the development and delivery of digital products and services to complement the company’s medicinal products, thereby enabling greater customer-centricity, increased understanding of Healthcare professionals/patients’ needs and improved adaptability in changing market demands. This approach is also evident in Novartis’s digital transformation strategy. By integrating digital technologies into drug development and patient care, Novartis has created a collaborative ecosystem that nurtures continuous innovation and adaptability.
For pharmaceutical companies, adopting digital platform-based operating models means embracing iterative development, continuous delivery, and rapid experimentation. This approach enables organisations to respond to real-time customer feedback and iterate quickly based on market insights. By integrating digital technologies into every aspect of their operations, pharmaceutical companies can enhance efficiency, reduce time to market, and stay ahead of the competition.

Benefits and Challenges

The shift towards diamond-shaped structures and digital platform-based operating models offers numerous benefits, including enhanced collaboration, increased innovation, and greater agility. These models nurtures an environment where creativity thrives, enabling pharmaceutical companies to adapt to market changes and patient needs rapidly. By breaking down silos, organisations can leverage diverse skill sets and perspectives, leading to more comprehensive and effective solutions.
However, the transition to these new ways of operating also presents significant challenges.

• Leadership Development: Leaders must evolve from traditional command-and-control styles to more facilitative and empowering roles. This requires new leadership skills focused on coaching, mentoring, and nurturing collaboration across diverse teams. Leaders must also manage ambiguity and guide their teams through continuous change and uncertainty.
• Organisational Design: Creating and sustaining diamond-shaped structures involves rethinking traditional job roles, reporting lines, and performance metrics. Organisations need to develop mechanisms to ensure clear accountability and decision-making processes without the rigidity of hierarchical structures. This shift can be difficult to manage, as it often requires a cultural transformation and a shift in mindset across all levels of the organisation.
• Change Management: Transitioning to these new models necessitates a robust change management strategy. Employees may resist changes to their roles and responsibilities, and there is a risk of confusion and decreased productivity during the transition period. Engaging people in highly participative change approaches like Whole Scale™ Change to build commitment, effective communication and training programmes are essential to support employees through the transition and ensure they understand and buy into the new organisational vision.
• Balancing Technology with Human-Centricity: While digital transformation can drive efficiency and innovation, there is a risk of overreliance on technology. It is crucial to maintain a human-centric approach, ensuring that technological advancements complement rather than replace the human elements of creativity, empathy, and interpersonal collaboration essential for organisational success.

If you would like to discuss this topic or anything else, please feel free to contact me.

Email me